Gebelikte Güncel Kozmetik Uygulamalar

Yıl 2022, , 206 - 217, 15.08.2022

Meyrem Doyranlı , Sevil Günaydın , Hüsniye Dinç Kaya

https://doi.org/10.54803/sauhsd.1092712

Öz

Kozmetik ürünlerin kullanımının olumsuz etki oluşturma riskinin yüksek olduğu dönemlerden biri de gebelik sürecidir. Kozmetik uygulamalar sırasında kullanılan birçok farmakolojik ajan Amerikan Gıda ve İlaç Dairesi tarafından, gebelik sırasındaki güvenlik profilinin yeterince değerlendirilmediği sebebi ile C kategorisinde sınıflandırılmıştır. Tüm kozmetik ajanların kullanımının güvenirliği desteklenene kadar, gebe kadınlara veya emziren annelere önerilmemelidir. Kozmetik uygulamaların güvenliğinin ortaya konulması için daha fazla randomize kontrollü çalışmaya ihtiyaç vardır. Ayrıca kadın sağlık hizmeti sağlayıcılarının gebelikte kozmetik ürün kullanımı ve kozmetik uygulamalar hakkında bilgi sahibi olmaları, güncel literatürü takip etmeleri ve gebeleri bilgilendirmeleri önemlidir. Bu derlemenin amacı gebelik döneminde yapılan kozmetik uygulamalar ve gebeliğe etkileri konusunda güncel bilgi sağlamaktır.

Anahtar Kelimeler

Botulium toksin, fetüs, gebelik, kimyasal madde, kozmetik

Current Cosmetic Procedures in Pregnancy

Öz

The use of cosmetic products during pregnancy is one of the times when there is a considerable risk of side effects. The American Food and Drug Administration has classified many pharmacological drugs used in cosmetic applications as category C since their safety profile during pregnancy has not been sufficiently investigated. It should not be suggested to pregnant women or nursing mother suntil the safety of all cosmetic agents has been established. To prove the safety of cosmetic applications, further randomized controlled studies are needed. Further more, it is critical for female health care providers to be knowledge able about the use of cosmetic items and applications during pregnancy, to keep up with current research, and to educate pregnant women. The aim of this review is to provide up-to-date information on cosmetic applications during pregnancy and their effects on pregnancy.

Anahtar Kelimeler

Botulium toxin, chemical matter, cosmetic, fetus, pregnancy

Kaynakça

• 1. Kışlalıoğlu S. Kozmetoloji Bilimi. İçinde: Kozmetik Bilimi. Editör: Yazan Y. Nobel Tıp Kitabevi, İstanbul; 2003. s. 3-9.
• 2. Sidle DM, Decker JR. Use of makeup, hairstyles, glasses and prosthetics as adjuncts to scar camouflage. Facial Plast Surg Clin North Am. 2011;19(3):481-489.
• 3. Wormuth M, Scheringer M, Vollenweider M, Hungerbühler K. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal. 2006;26(3):803-824.
• 4. Sade G, Özkan, H. Kozmetik ürünlerdeki bazı kimyasalların gebe, fetüs ve yenidoğan sağlığına etkisi. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi. 2020;17(3):473-477.
• 5. Durmaz E, Özmert, EN. Fitalatlar ve çocuk sağlığı. Çocuk Sağlığı ve Hastalıkları Dergisi. 2010;53:305-317.
• 6. Kartal Durmazlar SP, Eskioğlu F. Gebelikte Kozmetik Uygulamalar. Turkiye Klinikleri J Med Sci 2008;28(6):942-946.
• 7. Ragusa, A, Svelato A, Santacroce C, Catalano P, Notarstefano V, Carnevali O, et al. Plasticenta: First evidence of microplastics in human placenta. Environ Int. 2021;146:106274.
• 8. Bakar Dertlioğlu S, Çiçek D, Uçak H, Çelik H, Halisdemir N. Gebelikte gözlenen deri değişiklikleri ve gebelik dermatozlarının incelenmesi. Fırat Tıp Dergisi. 2011;16(4):170-174.
• 9. Teskereci G, Boz İ, Aydus HŞ. Stria gravidarumun önlenmesi için kullanılan tamamlayıcı terapilerin belirlenmesi. Turkderm: Turkish Archives of Dermatology and Venereology. 2018;52(1):29-32.
• 10. Bitirgen E, Köşüş A, Namlı Kalem M, Duran M, Köşüş N. Gebelikte cilt hastalıkları. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi. 2016;13(2):78-82.
• 11. Malik F, Boone J, Chopra S, Ghatak S. A novel “system” to aid the prevention of stretch marks during pregnancy: Results of a clinical trial, using a combination of a maternity support device and synergistic cosmetic formulations. Journal of the American Academy of Dermatology. 2014;70(5):Ab13.
• 12. Dai H, Liu Y, Zhu Y, Yu Y, Meng L. Study on the methodology of striae gravidarum severity evaluation. Biomed Eng Online. 2021;20(1):1-12.
• 13. Timur Taşhan S, Kafkasli A. The effect of bitter almond oil and massaging on striae gravidarum in primiparaous women. Journal Clin Nur. 2012;21(11‐12):1570-1576.
• 14. Hajhashemi M, Rafieian M, Rouhi Boroujeni HA, Miraj S, Memarian S, Keivani A, et al. The effect of aloe vera gel and sweet almond oil on striae gravidarum in nulliparous women. J Matern Fetal Neonatal Med. 2018;31(13):1703-1708.
• 15. García Hernández JÁ, Madera González D, Padilla Castillo M, Figueras Falcón T. Use of a specific anti‐stretch mark cream for preventing or reducing the severity of striae gravidarum. Randomized, double‐ blind, controlled trial. Int J Cosmet Sci. 2013;35(3):233-237.
• 16. Ersoy E, Ersoy AO, Yasar Celik E, Tokmak A, Ozler S, Tasci Y. Is it possible to prevent striae gravidarum? J Chin Med Assoc. 2016;79(5):272-275.
• 17. Sadat Z, Saberi F, Babaei M, Bagheri A, Nasiri S. Comparison of the effect of sesame and almond oil on the incidence of striae gravidarum. Nurs Midwifery Stud. 2020;9(4):208-214.
• 18. Çağlar AB, Saral S. Kozmetolojide toksisite sorunu. Turk J Dermatol. 2014;8(4):248-251.
• 19. Patel D, Narayana S, Krishnaswamy B. Trends in use of hair dye: A cross-sectional study. Int J Trichology. 2013;5(3):140-143.
• 20. Shishavan MK, Sayyah-Melli M, Rashid MR, Gharabaghi PM, Ghojazadeh M, Rahmani V, et al. The association of hair coloring during pregnancy with pregnancy and neonate outcomes: A cross-sectional study. Research Square. 2020:1-14.
• 21. Xie J, Liu YH, Li LF, Wu YM. A clinical analysis of fetal chromosomal aberration induced by paint and hair dye. Journal of Southern Medical University. 2010;30(7):1651-1653.
• 22. Couto AC, Ferreira JD, Rosa ACS, Pombo-De-Oliveira MS, Koifman S, Brazilian Collaborative Study Group of Infant Acute Leukemia. Pregnancy, maternal exposure to hair dyes and hair straightening cosmetics, and early age leukemia. Chem Biol Interact. 2013;205(1):46-52.
• 23. McCall EE, Olshan AF, Daniels JL. Maternal hair dye use and risk of neuroblastoma in offspring. Cancer Causes Control. 2005;16(6):743-748.
• 24. Jiang C, Hou Q, Huang Y, Ye J, Qin X, Zhang Y, et al. The effect of pre-pregnancy hair dye exposure on infant birth weight: A nested case-control study. BMC Pregnancy Childbirth. 2018;18(1):144.
• 25. Ball Arefiev KL, Hantash BM. Advances in the treatment of melasma: A review of the recent literature. Dermatol Surg. 2012;38(7):971-984.
• 26. Yamakoshi J, Sano A, Tokutake S, Saito M, Kikuchi M, Kubota Y, et al. Oral intake of proanthocyanidin‐rich extract from grape seeds improves chloasma. Phytother Res. 2004;18(11):895-899.
• 27. Elmore AR. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics. Int J Toxicol. 2005;24:51-111.
• 28. Ilknur T, Biçak MÜ, Demirtaşoğlu M, Ozkan S. Glycolic acid peels versus amino fruit acid peels in the treatment of melasma. Dermatol Surg. 2010;36(4):490-495.
• 29. Özgan Çelikel Ö, Ünal ES, Doğan Ö, Aksoy N. Akne vulgarisli gebelerde A vitamini düzeyi ve vücut kitle indeksinin incelenmesi. Abant Tıp Dergisi. 2021;10(1):65-71.
• 30. Vaughan Jones S, Ambros-Rudolph C, Nelson-Piercy C. Skin disease in pregnancy. BMJ. 2014;348:g3489.
• 31. Pugashetti R, Shinkai K. Treatment of acne vulgaris in pregnant patients. Dermatol Ther. 2013;26(4):302-311.
• 32. Aksoy B. Özel durumlarda tedavi. Turkderm-Turk Arch Dermatol Venereol. 2020;54(Suppl 1):45-49.
• 33. Dréno B, Blouin E, Moyse D, Bodokh I, Knol AC, Khammari A. Acne in pregnant women: A French survey. Acta Derm Venereol. 2014;94(1):82-83.
• 34. Ogé LK, Broussard A, Marshall MD. Acne vulgaris: Diagnosis and treatment. Am Fam Physician. 2019;100(8):475-484.
• 35. Yıldız H, Karabudak Abuaf Ö. Gebelik ve emzirme döneminde kozmesötik kullanımı. Turkderm-Türk Deri Hastalıkları ve Frengi Arşivi. 2013;47:194-199.
• 36. Pazyar N, Yaghoobi R, Bagherani N, Kazerouni A. A review of applications of tea tree oil in dermatology. Int J Dermatol. 2013;52(7):784-790.
• 37. Witmanowski H, Błochowiak K. The whole truth about botulinum toxin - A review. Adv Dermatol Allergol. 2020;37(6):853-861.
• 38. Terzioğlu A, Tuncalı D, Yüksel Barutçu A, Başer NT, Aslan G. Botulinum toksin A: Kozmetik uygulama ve literatürün gözden geçirilmesi. Türk Plast Rekonstr Est Cer Derg. 2005;13(3):185-190.
• 39. Newman WJ, Davis TL, Padaliya BB, Covington CD, Gill CE, Abramovitch AI, et al. Botulinum toxin type A therapy during pregnancy. Mov Disord. 2004;19(11):1384-1385.
• 40. Brin MF, Kirby RS, Slavotinek A, Miller‐Messana MA, Parker L, Yushmanova I, et al. Pregnancy outcomes following exposure to onabotulinumtoxinA. Pharmacoepidemiology and Drug Safety. 2016;25(2):179- 187.
• 41. Morgan JC, Iyer SS, Moser ET, Singer C, Sethi KD. Botulinum toxin A during pregnancy: A survey of treating physicians. J Neurol Neurosurg Psychiatry. 2006;77(1):117-119.
• 42. Wong HT, Khalil M, Ahmed F. OnabotulinumtoxinA for chronic migraine during pregnancy: A real world experience on 45 patients. J Headache Pain. 2020;21(1):1-6.
• 43. Krug H, Krause P, Kupsch A, Kühn AA. Safe administration of botulinum toxin type A injections during pregnancy: A report of two cases. Mov Disord Clin Pract. 2015;2(2):187-189.